id: NEW:slc6a3_gene_polymorphism_rs28363170_to_substance_use_disorder_any
name: SLC6A3 Gene Polymorphism (rs28363170) â†’ Substance Use Disorder (Any)
from_node:
  node_id: NEW:slc6a3_gene_polymorphism_rs28363170
  node_name: SLC6A3 Gene Polymorphism (rs28363170)
to_node:
  node_id: substance_use_disorder_any
  node_name: Substance Use Disorder (Any)
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: The SLC6A3 gene encodes the dopamine transporter, which regulates dopamine reuptake in neural
  synapses'
- 'Step 2: Polymorphisms in this gene (rs28363170 40-bp VNTR) may alter transporter expression and dopamine
  availability'
- 'Step 3: Dopaminergic pathways are central to reward processing and addiction vulnerability'
- 'Step 4: Altered dopamine signaling may influence susceptibility to prolonged substance use patterns'
- 'Step 5: However, this meta-analysis found NO statistically significant association under any inheritance
  mode'
evidence:
  quality_rating: A
  n_studies: 29
  primary_citation: 'Angeliki V Vogiatzoglou et al. 2024. "Genetic association of SLC6A3 (dopamine transporter)
    gene polymorphisms with personality disorders and substance abuse disorders: a systematic review and
    meta-analysis.." https://doi.org/10.1097/YPG.0000000000000375'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 29 studies with 5221 cases
    and 4822 controls
  - Prior studies reporting discrepant results on genetic predisposition for substance abuse disorders
    (per abstract)
  - Research on dopaminergic pathway gene variants in substance abuse (per abstract background)
  doi: 10.1097/YPG.0000000000000375
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: This meta-analysis of 29 studies (5221 cases, 4822 controls) found NO statistically significant
  association between SLC6A3 rs28363170 polymorphism and substance abuse disorders under any inheritance
  model. This null finding is important as it contradicts some prior studies and suggests that this particular
  genetic variant does not independently confer risk for substance use disorders, highlighting the complex,
  multifactorial nature of addiction.
quantitative_effects:
  sample_size: 10043
moderators:
- name: mode_of_inheritance
  direction: weakens
  strength: strong
  description: No statistically significant correlation was observed under any mode of inheritance (dominant,
    recessive, co-dominant)
structural_competency:
  equity_implications: This null genetic finding underscores that substance use disorders cannot be reduced
    to simple genetic determinism. Structural factors - including economic deprivation, trauma exposure,
    neighborhood drug availability, lack of treatment access, and policies around drug criminalization
    - likely play more significant roles in substance use disorder development than this genetic variant.
    The societal burden of substance abuse disorders mentioned in the abstract reflects structural conditions
    rather than individual genetic failings. Treatment approaches must address social determinants rather
    than focusing solely on biological predisposition.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.961267'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
